GL1X · GenesisL1 explorer

Research workbench

Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-356

Analyse Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-356 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FDW
Type
protein
Length
664 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q8WQX9
Ligands
D62, GAI, ZN, MG

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein333—Q8WQX9
B—protein331—Q8WQX9

Ligands and binding sites

  • D62 · (4as,8ar)-2-(1-{2-aminothieno[2,3-d]pyrimidin-4-yl}piperidin-4-yl)-4-(3,4- dimethoxyphenyl)-1,2,4A,5, 8,8A-hexahydrophthalazin-1-one · ligand · 2 copies · chains A, B
  • GAI · Guanidine · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6FDW · Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-356 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.